Literature DB >> 1314086

On the significance of in situ production of oestrogens in human breast cancer tissue.

M A Blankenstein1, I Maitimu-Smeele, G H Donker, J Daroszewski, A Milewicz, J H Thijssen.   

Abstract

We have previously shown that human breast cancer is autonomous in the regulation of its intra-tissue oestradiol concentration. Breast fatty tissue does not have this capacity, but rather reflects changes in the peripheral oestradiol concentration. To further evaluate the relative contribution of breast cancer and fatty tissue to the maintenance of tumour oestradiol we investigated whether a tumour-directed gradient in aromatase activity and oestrogen levels existed in mastectomy specimens. No such gradient was found, however, for aromatase, oestrone, oestradiol and their sulphates. Aromatase activity (expressed per gram of tissue) and the concentrations of oestradiol, oestradiol sulphate and oestrone sulphate were higher in tumour than in breast fatty tissue. Fatty tissue had a higher oestrone concentration. It is tentatively concluded that breast tumour aromatase activity is more important for the maintenance of tumour oestradiol levels than aromatase in breast fatty tissue.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314086     DOI: 10.1016/0960-0760(92)90443-m

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  10 in total

Review 1.  Estrogens in the breast tissue: a systematic review.

Authors:  Lusine Yaghjyan; Graham A Colditz
Journal:  Cancer Causes Control       Date:  2011-02-01       Impact factor: 2.506

Review 2.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

3.  Breast ductal lavage for assessment of breast cancer biomarkers.

Authors:  Robert Treat Chatterton; Noah P Parker; Mito Habe-Evans; Michele Bryk; Denise M Scholtens; Seema A Khan
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

4.  Measurement of sex steroid hormones in breast adipocytes: methods and implications.

Authors:  Roni T Falk; Elisabet Gentzschein; Frank Z Stanczyk; Louise A Brinton; Montserrat Garcia-Closas; Olga B Ioffe; Mark E Sherman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

5.  Growth hormone mRNA in mammary gland tumors of dogs and cats.

Authors:  J A Mol; E van Garderen; P J Selman; J Wolfswinkel; A Rijinberk; G R Rutteman
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

6.  Occult breast tumor reservoir: biological properties and clinical significance.

Authors:  Richard J Santen; Wei Yue; Daniel F Heitjan
Journal:  Horm Cancer       Date:  2013-04-30       Impact factor: 3.869

Review 7.  The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer.

Authors:  Atul Purohit; Simon P Newman; Michael J Reed
Journal:  Breast Cancer Res       Date:  2002-01-14       Impact factor: 6.466

8.  The Prevalence of Systemic Rheumatic Diseases Among Breast Cancer Patients and Its Relationship With Survival.

Authors:  Veli Sunar; Öztürk Ateş; Alma Korcali Aslan; Yusuf Karakaş; Mustafa Kadri Altundağ
Journal:  Arch Rheumatol       Date:  2018-08-16       Impact factor: 1.472

9.  Oestradiol enhances tumour regression induced by B7-1/IL-2 adenoviral gene transfer in a murine model of breast cancer.

Authors:  C Dabrosin; K Palmer; J Gauldie
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

10.  HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women.

Authors:  Anja Kathrin Wege; Dominik Chittka; Stefan Buchholz; Monika Klinkhammer-Schalke; Simone Diermeier-Daucher; Florian Zeman; Olaf Ortmann; Gero Brockhoff
Journal:  Breast Cancer Res       Date:  2018-11-20       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.